Pock man works on Covid-19 cure

A former Woldgate School student from Pocklington has been working on a cure for Covid-19 and now believes he has found an effective way to combat the virus.

Thursday, 28th January 2021, 9:30 am
Successful businessmen Adam Dixon made his breakthrough following a four-year investigation into curing his ADHD.

Adam Dixon is the co-founder of the very successful agriculture start-up Phytoponics, for which he received a UN award.

He has submitted his findings to the British Medical Journal, where it is currently undergoing peer review.

Mr Dixon made his breakthrough following a four-year personal investigation into curing his ADHD, where he used his scientific ability and lateral thinking to advance the field of neuroendocrinology.

He successfully managed his condition in March 2020 with a combination of a oxytocin nasal spray of the cuddle hormone oxytocin and a former soviet anti-fatigue drug after he found his stimulant treatment stopped working over time.

He said: “Following a break-up and a stressful time at work, I started to notice my ADHD medication stopped working. I tried dopamine detoxing, meditation, and self-discipline but I hit a glass ceiling and wanted to push past it.”

His extensive research uncovered that the reason why his treatment wasn’t helping him was likely to be due to the build up of a hormone called dynorphin.

Dynorphin, which Adam calls “the death hormone” is known to be behind many diseases, addiction, aging and inflammation and is behind the burn-out and fatigue you experience after stress or trauma.

Mr Dixon’s preliminary

research uncovered how oxytocin can be used to reduce dynorphin by down-regulating dynorphin’s gene – PDYN.

He then pieced together a hypothesis that the Russian anti-fatigue works by downregulating the gene.

Mr Dixon said: “When I tried them together, both legal supplements, the effects were almost instant.

“I suddenly started being finally able to get up at 6am in the morning full of beans, have full focus and deep thought, stress resilience and excellent social skills.

“I then read about dynorphin being behind the loss of smell in Covid-19 and it rang a bell, could my treatment also be applicable to the virus?

“I’m currently planning pre-clinical trials to get this tested as soon as possible and rolled out, and got connected to another researcher called Dr Phuoc-Tan Diep in Lancaster who wrote the first few papers proposing Covid-19 treatment with oxytocin after he found that massages (releasing oxytocin) benefited his wife in recovery after a post-viral illness.

“What our study shows is that Covid-19, viral infection, stress, and trauma all raise the body’s set point of dynorphin at a gene called PDYN.

“The only way to reduce that naturally is via oxytocin, which you get from socialising, exercise, sunlight, love and bonding. Without it, the immune system is suppressed.

“My paper identifies this and also the link between low oxytocin and HIV, as the virus reduces a body’s expression of oxytocin and jacks up dynorphin.”

If clinical trials validate the efficacy of methods outlined in the study, then Adam’s patent pending neuroendocrine immunomodulation treatment could be used to treat a host of diseases, including Covid-19, depression, diabetes, HIV, multiple sclerosis, obesity, addition and post-viral disorders.

People can follow Adam’s story via his blog at www.humanalchemy.co.uk/knowledge